GRIFOLS, S.A. 26/10/2021 08:34 GRIFOLS, S.A. On corporate transactions: mergers, acquisitions and others Continuation of the inside information note filed on 17 September 2021. Register number: 1110 Related to communication no. 1060 dated 17/09/2021 (07:38) 17/09/2021 07:45 GRIFOLS, S.A. On corporate transactions: mergers, acquisitions and others Grifols, as a continuation of the Inside Information sent this morning, informs that today, at 11 am CET, there will be a virtual meeting with investors and analysts. Register number: 1061 Related to communication no. 1060 dated 17/09/2021 (07:38) 17/09/2021 07:38 GRIFOLS, S.A. On corporate transactions: mergers, acquisitions and others Grifols informs today that it has entered into a share purchase agreement. By means of this acquisition, Grifols will acquire the existing share capital of Tiancheng (Germany) Pharmaceutical Holdings AG. Register number: 1060 30/07/2020 08:46 GRIFOLS, S.A. On P&L Grifols files 1H2020 information Register number: 397 08/06/2020 17:37 GRIFOLS, S.A. On business and financial situation COVID-19 impacts Register number: 272 27/03/2020 08:42 GRIFOLS, S.A. On corporate transactions: mergers, acquisitions and others Grifols informs that all legal requirements requested by the People's Republic of China and the United States for the closing of the transaction between Shanghai RAAS Blood Products Co. Ltd. and Grifols have been consummated. Register number: 121 25/03/2020 20:46 GRIFOLS, S.A. On strategic plans and profit forecasts Grifols Announces Formal Collaboration with US Government to Produce the First Treatment Specifically Targeting COVID-19 Register number: 116